Aquaporin 11 as a new predictive biomarker of overall survival and platinum-based chemotherapy response in lung adenocarcinoma patients

被引：2
|
作者：
Sharpnack, Michael [1 ]
Carbone, David P. [1 ]
Dikov, Mikhail M. [1 ]
Tchekneva, Elena E. [1 ]
机构：
[1] Ohio State Unibvers, Columbus, OH USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2620
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2620
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma
    Kuchitsu, Yuki
    Nagashio, Ryo
    Igawa, Satoshi
    Kusuhara, Seiichiro
    Tsuchiya, Benio
    Ichinoe, Masaaki
    Satoh, Yukitoshi
    Naoki, Katsuhiko
    Murakumo, Yoshiki
    Saegusa, Makoto
    Sato, Yuichi
    [J]. BIOMEDICAL RESEARCH-TOKYO, 2020, 41 (01): : 53 - 65
  • [2] An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
    Qi, Lishuang
    Li, Yang
    Qin, Yuan
    Shi, Gengen
    Li, Tianhao
    Wang, Jiasheng
    Chen, Libin
    Gu, Yunyan
    Zhao, Wenyuan
    Guo, Zheng
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (12) : 1513 - 1519
  • [3] An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
    Lishuang Qi
    Yang Li
    Yuan Qin
    Gengen Shi
    Tianhao Li
    Jiasheng Wang
    Libin Chen
    Yunyan Gu
    Wenyuan Zhao
    Zheng Guo
    [J]. British Journal of Cancer, 2016, 115 : 1513 - 1519
  • [4] COMPARISON OF GEFITINIB AND PLATINUM-BASED CHEMOTHERAPY AND ONLY PLATINUM-BASED CHEMOTHERAPY TO TREAT LUNG ADENOCARCINOMA
    Yang, L.
    Fan, J. H.
    Liu, L. L.
    Su, Y.
    Lu, D.
    Huang, J. Y.
    Zhang, H.
    Li, Y.
    Huo, H. D.
    Du, Z. H.
    Liu, G. T.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 613 - 618
  • [5] Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy
    Geens, Margot
    Stappers, Sofie
    Konings, Heleen
    De Winter, Benedicte Y.
    Specenier, Pol
    Van Meerbeeck, Jan P.
    Verpooten, Gert A.
    Abrams, Steven
    Janssens, Annelies
    Peeters, Marc
    Van de Heyning, Paul
    Vanderveken, Olivier M.
    Ledeganck, Kristien J.
    [J]. PLOS ONE, 2021, 16 (06):
  • [6] MiRNA-21 A biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer
    Gao, Wen
    Lu, Xiao
    Liu, Lingxiang
    Xu, Jing
    Feng, Dongjie
    Shu, Yongqian
    [J]. CANCER BIOLOGY & THERAPY, 2012, 13 (05) : 330 - 340
  • [7] XPG polymorphisms and their association with lung cancer susceptibility, overall survival and response in North Indian patients treated with platinum-based doublet chemotherapy
    Lawania, Shweta
    Singh, Navneet
    Behera, Digambar
    Sharma, Siddharth
    [J]. FUTURE ONCOLOGY, 2019, 15 (02) : 151 - 165
  • [8] Association of BAFFR expression in CAFs with overall survival and response to platinum-based chemotherapy in NSCLC.
    Dimtrakopoulos, Fotinos-Ioannis D.
    Kottorou, Anastasia E.
    Antonacopoulou, Anna G.
    Nikolakopoulos, Achilleas
    Panagopoulos, Nikolaos
    Kalofonou, Melpomeni
    Dougenis, Dimitrios
    Koutras, Angelos
    Makatsoris, Thomas
    Tzelepi, Vasiliki
    Kalofonos, Haralabos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [10] Genetic variations predicting cisplatin cytotoxicity associated with the overall survival in lung cancer patients receiving platinum-based chemotherapy
    Tan, Xiang-Lin
    Moyer, Ann M.
    Schaid, Daniel J.
    Niu, Nifang
    Batzler, Anthony
    Li, Liang
    Sun, Zhifu
    Yang, Ping
    Wang, Liewei
    [J]. CANCER RESEARCH, 2011, 71
12345